Early-stage executive management of four life science companies and a leading industry organization serving the life science sector. Senior executive experience in planning, launching, funding, growing, and merging/acquiring/exiting companies in the biopharmaceutical field. Career focus has been organizing and building new companies that apply fundamental advances in biomedical science to the development of breakthrough drug products. These include start-up ventures that established foundational technologies in the fields of human gene therapy (Viagene, Inc., employee no. 1, acquired by Chiron, later Novartis); small molecule regulation of kinase/ligase gene transcription pathways (Signal Pharmaceuticals, CFO, acquired by Celgene); novel stem cell regenerative and anti-cancer therapies, acquired in corp. development position at Celgene; and highly brain penetrant, oncogene-targeted therapeutics for neuro-oncology indications (UCLA spin-out Katmai Pharmaceuticals, current President, CEO). Held executive management positions principally in finance and business and corporate development at both private and public VC-backed biotech companies, including the founding head of finance and business development at Viagene, CFO at Signal Pharmaceuticals, V.P. Finance and Corporate Planning at Celgene Corp., and launch President, CEO at Katmai Pharmaceuticals (present). During biotech career, organized and directed all G&A functions.Executed a large and diverse range of equity, debt, in/out licensing, R&D partnering, and M&A transactions across major international pharmaceutical markets, including the U.S., Europe, and Japan. At Celgene, primary responsibility for corporate development activities, including mergers and acquisitions, strategic investments, and long-range strategic and financial planning. In addition to private sector work, conceived, co-founded, and currently serve as board chairman for one of the two largest life science strategic procurement organizations worldwide, Core by BIOCOM California, with offices in San Diego, San Francisco, Los Angeles, Washington, and Tokyo serving over 1,700 member companies, at over 3,500 sites, and generating over $850MM annual group purchasing volume.MBA with extended fellowship studies in corporate finance from the University of Southern California (USC). Recipient of May International Fellowship and served as President of the graduate business school’s Entrepreneur Association.